東華大學圖書館 |

Language: English

Help

回圖書館首頁

手機版館藏查詢

Back

Switch To: Labeled | MARC Mode | ISBD

Mechanisms of tumorigenesis in the i...

Looyenga, Brendan David.

Linked to FindBook

Google Book

Amazon

博客來

Mechanisms of tumorigenesis in the inhibin-null mouse: An analysis of dysregulated TGF-beta family signaling in steroidogenic organs.

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Mechanisms of tumorigenesis in the inhibin-null mouse: An analysis of dysregulated TGF-beta family signaling in steroidogenic organs./
Author:	Looyenga, Brendan David.
Description:	292 p.
Notes:	Adviser: Gary D. Hammer.
Contained By:	Dissertation Abstracts International67-10B.
Subject:	Biology, Cell. -
Online resource:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3238023
ISBN:	9780542921827

Mechanisms of tumorigenesis in the inhibin-null mouse: An analysis of dysregulated TGF-beta family signaling in steroidogenic organs.
Looyenga, Brendan David.

Mechanisms of tumorigenesis in the inhibin-null mouse: An analysis of dysregulated TGF-beta family signaling in steroidogenic organs. - 292 p.

Adviser: Gary D. Hammer.

Thesis (Ph.D.)--University of Michigan, 2006.

The transforming growth factor-beta (TGFbeta) family of signaling ligands encompasses a group of highly conserved proteins that play critical roles in metazoan development and physiology. TGFbeta family ligands signal through a membrane complex composed of TypeI and TypeII receptors, which transduce intracellular signals via Smad proteins. Activated Smad proteins act as promoter-specific transcription factors to induce changes in cellular growth and differentiation. Inhibin is an atypical member of the TGFbeta family, which selectively inhibits signaling by other TGFbeta family members. Inhibin is classically understood to antagonize signaling by activin, a canonical TGFbeta ligand that signals through Smad2 and Smad3. Opposing interactions between inhibin and activin regulate the function of the hypothalamic-pituitary-gonadal (HPG) axis and steroidogenic cell proliferation in the gonads. Inhibin-null (Inha-/-) mice display defects in both processes, exhibiting elevated follicle stimulating hormone (FSH) levels and estrogen-secreting gonadal tumors. Inha-/- mice develop estrogen-secreting adrenocortical neoplasms upon surgical gonadectomy, indicating that inhibin also regulates adrenocortical cell growth. The work presented in this thesis has attempted to elucidate several aspects of gonadal and adrenal tumorigenesis in Inha-/- mice, including the cellular identity of these neoplasms and signaling mechanisms involved in tumorigenesis. My studies have revealed that the adrenocortical neoplasms in Inha-/- mice are derived from misspecified adrenocortical stem/progenitor cells, which undergo a change in cellular fate to form gonadal tumors in the adrenal. These tumors have similar steroidogenic and transcriptional profiles to Inha-/- gonadal tumors, suggesting that the tumor-suppressing mechanism of inhibin is conserved between the gonads and adrenal. This assertion is supported by the common dependence of both tumor types on Smad3, which is required for efficient tumor cell proliferation. Genetic removal of Smad3 from Inha-/- mice disrupts mitogenic signaling by both activin and follicle stimulating hormone, and dramatically attenuates disease progression in the adrenal and gonad. Despite this similarity, tumorigenesis in the Inha-/- adrenal cortex may also involve unique mechanisms independent of activin signaling. My studies particularly implicate a novel interaction between inhibin and TGFbeta2 in adrenocortical tumor initiation, suggesting that inhibin may play multiple complex roles in cell fate determination and cellular growth suppression in steroidogenic tissues.

ISBN: 9780542921827Subjects--Topical Terms:

1017686
Biology, Cell.

Mechanisms of tumorigenesis in the inhibin-null mouse: An analysis of dysregulated TGF-beta family signaling in steroidogenic organs.
LDR:03575nam 2200289 a 45 001 970668
005 20110921
008 110921s2006 eng d
020 $a 9780542921827
035 $a (UMI)AAI3238023
035 $a AAI3238023
040 $a UMI $c UMI
100 1 $a Looyenga, Brendan David. $3 1294704
245 1 0 $a Mechanisms of tumorigenesis in the inhibin-null mouse: An analysis of dysregulated TGF-beta family signaling in steroidogenic organs.
300 $a 292 p.
500 $a Adviser: Gary D. Hammer.
500 $a Source: Dissertation Abstracts International, Volume: 67-10, Section: B, page: 5565.
502 $a Thesis (Ph.D.)--University of Michigan, 2006.
520 $a The transforming growth factor-beta (TGFbeta) family of signaling ligands encompasses a group of highly conserved proteins that play critical roles in metazoan development and physiology. TGFbeta family ligands signal through a membrane complex composed of TypeI and TypeII receptors, which transduce intracellular signals via Smad proteins. Activated Smad proteins act as promoter-specific transcription factors to induce changes in cellular growth and differentiation. Inhibin is an atypical member of the TGFbeta family, which selectively inhibits signaling by other TGFbeta family members. Inhibin is classically understood to antagonize signaling by activin, a canonical TGFbeta ligand that signals through Smad2 and Smad3. Opposing interactions between inhibin and activin regulate the function of the hypothalamic-pituitary-gonadal (HPG) axis and steroidogenic cell proliferation in the gonads. Inhibin-null (Inha-/-) mice display defects in both processes, exhibiting elevated follicle stimulating hormone (FSH) levels and estrogen-secreting gonadal tumors. Inha-/- mice develop estrogen-secreting adrenocortical neoplasms upon surgical gonadectomy, indicating that inhibin also regulates adrenocortical cell growth. The work presented in this thesis has attempted to elucidate several aspects of gonadal and adrenal tumorigenesis in Inha-/- mice, including the cellular identity of these neoplasms and signaling mechanisms involved in tumorigenesis. My studies have revealed that the adrenocortical neoplasms in Inha-/- mice are derived from misspecified adrenocortical stem/progenitor cells, which undergo a change in cellular fate to form gonadal tumors in the adrenal. These tumors have similar steroidogenic and transcriptional profiles to Inha-/- gonadal tumors, suggesting that the tumor-suppressing mechanism of inhibin is conserved between the gonads and adrenal. This assertion is supported by the common dependence of both tumor types on Smad3, which is required for efficient tumor cell proliferation. Genetic removal of Smad3 from Inha-/- mice disrupts mitogenic signaling by both activin and follicle stimulating hormone, and dramatically attenuates disease progression in the adrenal and gonad. Despite this similarity, tumorigenesis in the Inha-/- adrenal cortex may also involve unique mechanisms independent of activin signaling. My studies particularly implicate a novel interaction between inhibin and TGFbeta2 in adrenocortical tumor initiation, suggesting that inhibin may play multiple complex roles in cell fate determination and cellular growth suppression in steroidogenic tissues.
590 $a School code: 0127.
650 4 $a Biology, Cell. $3 1017686
650 4 $a Biology, Molecular. $3 1017719
650 4 $a Biology, Physiology. $3 1017816
690 $a 0307
690 $a 0379
690 $a 0719
710 2 0 $a University of Michigan. $3 777416
773 0 $t Dissertation Abstracts International $g 67-10B.
790 $a 0127
790 1 0 $a Hammer, Gary D., $e advisor
791 $a Ph.D.
792 $a 2006
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3238023